Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome.
Pranzatelli MR, Tate ED, Travelstead AL, Barbosa J, Bergamini RA, Civitello L, Franz DN, Greffe BS, Hanson RD, Hurwitz CA, Kalinyak KA, Kelfer H, Khakoo Y, Mantovani JF, Nicholson SH, Sanders JM, Wegner S.
Pranzatelli MR, et al. Among authors: barbosa j.
J Pediatr Hematol Oncol. 2006 Sep;28(9):585-93. doi: 10.1097/01.mph.0000212991.64435.f0.
J Pediatr Hematol Oncol. 2006.
PMID: 17006265